K163272 is an FDA 510(k) clearance for the AXIOS Stent and Electrocautery Enhanced Delivery System. This device is classified as a Pancreatic Stent, Covered, Metallic, Removable (Class II - Special Controls, product code PCU).
Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on February 18, 2017, 89 days after receiving the submission on November 21, 2016.
This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5015. To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts.